Vaxxa AB (NGM:VAXXA)
Sweden
· Delayed Price · Currency is SEK 0.552
+0.008 (1.47%)
At close: Apr 28, 2026
Vaxxa AB Revenue
In the year 2025, Vaxxa AB had annual revenue of 77.45M SEK, down -8.01%. Vaxxa AB had revenue of 23.21M in the quarter ending December 31, 2025, with 23.89% growth.
Revenue
77.45M
Revenue Growth
-8.01%
P/S Ratio
0.31
Revenue / Employee
8.61M
Employees
9
Market Cap
23.94M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nattaro Labs AB | 6.02M |
| Level Bio AB | 33.51M |
| Goobit Group AB | 240.28M |
| PolarCool AB | 2.40M |
| Transiro Holding AB | -9.11M |
| edyoutec AB | 17.05M |
| LightAir AB | 14.43M |
| Qbrick AB | 32.66M |